7 research outputs found
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
The orphan G protein-coupled receptor GPR55 has been directly or indirectly
related to basic alterations that drive malignant growth: uncontrolled cancer cell
proliferation, sustained angiogenesis, and cancer cell adhesion and migration.
However, little is known about the involvement of this receptor in metastasis.
Here, we show that elevated GPR55 expression in human tumors is associated with
the aggressive basal/triple-negative breast cancer population, higher probability
to develop metastases, and therefore poor patient prognosis. Activation of GPR55
by its proposed endogenous ligand lysophosphatidylinositol confers pro-invasive
features on breast cancer cells both in vitro and in vivo. Specifically, this effect is
elicited by coupling to Gq/11 heterotrimeric proteins and the subsequent activation,
through ERK, of the transcription factor ETV4/PEA3. Together, these data show that
GPR55 promotes breast cancer metastasis, and supports the notion that this orphan
receptor may constitute a new therapeutic target and potential biomarker in the
highly aggressive triple-negative subtypeThis work was supported by grants from Spanish Ministry of Economy and Competitiveness [PI11/00295 to CS, PI14/01101 to CS and EP-G, SAF2013-46183-R to MQ, and SAF2014-54705-R to MV-M, supported with European Regional Development (FEDER) funds] and Madrid Regional Government (S2010/BMD-2308 to MG, and 2010/BMD-2359 to MQ). EPG was a recipient of a Postdoctoral Research Contract from Fundación Científica Asociación Española Contra el Cáncer and a Federation of the Societies of Biochemistry and Molecular Biology (FEBS) Short-term Fellowship. SB-B and SC-L are recipients of a Formación de Profesorado Universitario (FPU) fellowship and a Ramón y Cajal research contract, respectively, from the Spanish Ministry of Economy and Competitivenes
Minimal information for studies of extracellular vesicles 2018 (MISEV2018):a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points
Evaluation of appendicitis risk prediction models in adults with suspected appendicitis
Background
Appendicitis is the most common general surgical emergency worldwide, but its diagnosis remains challenging. The aim of this study was to determine whether existing risk prediction models can reliably identify patients presenting to hospital in the UK with acute right iliac fossa (RIF) pain who are at low risk of appendicitis.
Methods
A systematic search was completed to identify all existing appendicitis risk prediction models. Models were validated using UK data from an international prospective cohort study that captured consecutive patients aged 16–45 years presenting to hospital with acute RIF in March to June 2017. The main outcome was best achievable model specificity (proportion of patients who did not have appendicitis correctly classified as low risk) whilst maintaining a failure rate below 5 per cent (proportion of patients identified as low risk who actually had appendicitis).
Results
Some 5345 patients across 154 UK hospitals were identified, of which two‐thirds (3613 of 5345, 67·6 per cent) were women. Women were more than twice as likely to undergo surgery with removal of a histologically normal appendix (272 of 964, 28·2 per cent) than men (120 of 993, 12·1 per cent) (relative risk 2·33, 95 per cent c.i. 1·92 to 2·84; P < 0·001). Of 15 validated risk prediction models, the Adult Appendicitis Score performed best (cut‐off score 8 or less, specificity 63·1 per cent, failure rate 3·7 per cent). The Appendicitis Inflammatory Response Score performed best for men (cut‐off score 2 or less, specificity 24·7 per cent, failure rate 2·4 per cent).
Conclusion
Women in the UK had a disproportionate risk of admission without surgical intervention and had high rates of normal appendicectomy. Risk prediction models to support shared decision‐making by identifying adults in the UK at low risk of appendicitis were identified
Caracterización functional de las primeras mutaciones en el proto-oncogén Vav1 descritas en tumores humanos
Trabajo fin de Máster realizado por el graduado en Bioquímica Rodrigo Hernando Llorente para optar al titulo en Máster en Biología y Clínica del Cáncer.El proto-oncogén Vav1 es un factor intercambiador de nucleótidos de guanina (GEF) de GTPasas de la familia Rho/Rac con un papel importante en tumorogénesis, aunque solo parcialmente caracterizado. Por ejmplo, la expresión ectópica de Vav1 está involucrada en la patofisiología de ciertos tipos tumorales. Además, la pérdida de la conformación autoinhibida por deleciones en los dominios iniciales (Δ1-186) y finales (Δ835-845) de la molécula o sustituciones en las tirosinas reguladoras por residuos fosfomiméticos dan lugar a versiones oncogénicas con capacidad transformante. Recientemente se han descrito, por primera vez en tumores humanos, mutaciones, deleciones y fusiones génicas en Vav1. En este trabajo, hemos clonado y analizado la actividad biológica de los principales mutantes descritos, caracterizando funcionalmente dichas alteraciones según su efecto sobre la actividad catalítica y no catalítica de Vav1.Peer Reviewe
Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles ("MISEV") guidelines for the field in 2014. We now update these "MISEV2014" guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
The last decade has seen a sharp increase in the number
of scientific publications describing physiological and
pathological functions of extracellular vesicles (EVs), a
collective term covering various subtypes of cell-released,
membranous structures, called exosomes, microvesicles,
microparticles, ectosomes, oncosomes, apoptotic bodies, and many
other names. However, specific issues arise when working with
these entities, whose size and amount often make them difficult
to obtain as relatively pure preparations, and to characterize
properly. The International Society for Extracellular Vesicles
(ISEV) proposed Minimal Information for Studies of Extracellular
Vesicles ("MISEV") guidelines for the field in 2014. We now
update these "MISEV2014" guidelines based on evolution of the
collective knowledge in the last four years. An important point
to consider is that ascribing a specific function to EVs in
general, or to subtypes of EVs, requires reporting of specific
information beyond mere description of function in a crude,
potentially contaminated, and heterogeneous preparation. For
example, claims that exosomes are endowed with exquisite and
specific activities remain difficult to support experimentally,
given our still limited knowledge of their specific molecular
machineries of biogenesis and release, as compared with other
biophysically similar EVs. The MISEV2018 guidelines include
tables and outlines of suggested protocols and steps to follow
to document specific EV-associated functional activities.
Finally, a checklist is provided with summaries of key points